Full Press Release Details
ifrs-full:IssuedCapitalMember
ifrs-full:OtherEquityInterestMember
ifrs-full:RetainedEarningsMember
ifrs-full:AccumulatedOtherComprehensiveIncomeMember
ifrs-full:IssuedCapitalMember
ifrs-full:OtherEquityInterestMember
ifrs-full:RetainedEarningsMember
ifrs-full:AccumulatedOtherComprehensiveIncomeMember
ifrs-full:IssuedCapitalMember
ifrs-full:OtherEquityInterestMember
ifrs-full:RetainedEarningsMember
ifrs-full:AccumulatedOtherComprehensiveIncomeMember
ifrs-full:IssuedCapitalMember
ifrs-full:OtherEquityInterestMember
ifrs-full:RetainedEarningsMember
ifrs-full:AccumulatedOtherComprehensiveIncomeMember
ifrs-full:IssuedCapitalMember
ifrs-full:OtherEquityInterestMember
ifrs-full:RetainedEarningsMember
ifrs-full:AccumulatedOtherComprehensiveIncomeMember
ifrs-full:IssuedCapitalMember
ifrs-full:OtherEquityInterestMember
ifrs-full:RetainedEarningsMember
ifrs-full:AccumulatedOtherComprehensiveIncomeMember
AEZS:LicenseFeesMember
AEZS:LicenseFeesMember
AEZS:LicenseFeesMember
AEZS:LicenseFeesMember
AEZS:DevelopmentServicesMember
AEZS:DevelopmentServicesMember
AEZS:DevelopmentServicesMember
AEZS:DevelopmentServicesMember
AEZS:ProductSalesMember
AEZS:ProductSalesMember
AEZS:ProductSalesMember
AEZS:ProductSalesMember
AEZS:RoyaltiesMember
AEZS:RoyaltiesMember
AEZS:RoyaltiesMember
AEZS:RoyaltiesMember
AEZS:SupplyChainMember
AEZS:SupplyChainMember
AEZS:SupplyChainMember
AEZS:SupplyChainMember
ifrs-full:GoodsOrServicesTransferredOverTimeMember
ifrs-full:GoodsOrServicesTransferredOverTimeMember
ifrs-full:GoodsOrServicesTransferredOverTimeMember
ifrs-full:GoodsOrServicesTransferredOverTimeMember
ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember
ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember
ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember
ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember
AEZS:UnsatisfiedPerformanceObligationsMember
AEZS:IndicationPerformanceObligationMember
AEZS:PediatricIndicationPerformanceMember
AEZS:NovoNordiskHealthCareAGMember
AEZS:NovoNordiskHealthCareMember
AEZS:PharmanoviaMember
AEZS:NKMeditechMember
AEZS:NovoNordiskHealthCareMember
AEZS:ConsilientHealthMember
AEZS:NKMeditechMember
ifrs-full:PensionDefinedBenefitPlansMember
AEZS:OtherBenefitPlansMember
ifrs-full:PensionDefinedBenefitPlansMember
AEZS:OtherBenefitPlansMember
ifrs-full:PensionDefinedBenefitPlansMember
AEZS:OtherBenefitPlansMember
AEZS:ShareholdersAndBoardOfDirectorsMember
AEZS:DeferredStockUnitsMember
AEZS:TwoThousandEighteenLongTermIncentivePlanMember
AEZS:TwoThousandEighteenLongTermIncentivePlanMember
AEZS:DeferredShareUnitMember
AEZS:DeferredShareUnitMember
AEZS:DeferredShareUnitMember
AEZS:DeferredShareUnitMember
AEZS:DeferredShareUnitMember
AEZS:DeferredShareUnitMember
AEZS:DeferredShareUnitMember
AEZS:DeferredShareUnitMember
AEZS:DeferredShareUnitMember
AEZS:DeferredShareUnitMember
AEZS:EmployeeStockOption1DeferredStockUnitsMember
AEZS:EmployeeStockOption1DeferredStockUnitsMember
AEZS:EmployeeStockOption1DeferredStockUnitsMember
AEZS:EmployeeStockOption1DeferredStockUnitsMember
ifrs-full:NotLaterThanOneYearMember
AEZS:OneToThreeYearsMember
AEZS:FourToFiveYearsMember
ifrs-full:LaterThanFiveYearsMember
ifrs-full:TopOfRangeMember
Condensed Interim Consolidated Financial Statements
As of June 30, 2023, and for the three and six months ended
June 30, 2023, and 2022
(In thousands of US dollars)
| Condensed Interim Consolidated Statements of Financial Position | 2 |
| Condensed Interim Consolidated Statements of Changes in Shareholders' Equity | 3 |
| Condensed Interim Consolidated Statements of Loss and Comprehensive Loss | 4 |
| Condensed Interim Consolidated Statements of Cash Flows | 5 |
| Notes to Condensed Interim Consolidated Financial Statements | 6 |
Interim Consolidated Statements of Financial Position
thousands of US dollars)
| As of June 30, 2023 | As of December 31, 2022 | |||||||
| $ | $ | |||||||
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | 42,186 | 50,611 | ||||||
| Trade and other receivables | 185 | 732 | ||||||
| Inventory | 93 | 229 | ||||||
| Income taxes receivable | 792 | 1,428 | ||||||
| Prepaid expenses and other current assets | 2,637 | 2,488 | ||||||
| Total current assets | 45,893 | 55,488 | ||||||
| Non-current assets | ||||||||
| Restricted cash equivalents | 325 | 322 | ||||||
| Property and equipment | 265 | 216 | ||||||
| Total non-current assets | 591 | 538 | ||||||
| Total assets | 46,483 | 56,026 | ||||||
| LIABILITIES | ||||||||
| Current liabilities | ||||||||
| Payables and accrued liabilities | 3,572 | 3,828 | ||||||
| Provisions | 49 | 45 | ||||||
| Income taxes payable | 109 | 108 | ||||||
| Deferred revenues (note 3) | 202 | 2,949 | ||||||
| Lease liabilities | 145 | 114 | ||||||
| Total current liabilities | 4,077 | 7,044 | ||||||
| Non-current liabilities | ||||||||
| Deferred revenues (note 3) | 1,580 | 1,684 | ||||||
| Deferred gain | 111 | 110 | ||||||
| Lease liabilities | 85 | 65 | ||||||
| Employee future benefits (note 4) | 11,381 | 11,159 | ||||||
| Provisions | 170 | 188 | ||||||
| Total non-current liabilities | 13,327 | 13,206 | ||||||
| Total liabilities | 17,404 | 20,250 | ||||||
| Shareholders' equity | ||||||||
| Share capital (note 5) | 293,410 | 293,410 | ||||||
| Warrants | 5,085 | 5,085 | ||||||
| Contributed surplus | 90,654 | 90,332 | ||||||
| Deficit | ( 358,936 | ) | ( 352,084 | ) | ||||
| Accumulated other comprehensive loss | ( 1,134 | ) | ( 967 | ) | ||||
| Total Shareholders' equity | 29,079 | 35,776 | ||||||
| Total liabilities and shareholders' equity | 46,483 | 56,026 |
accompanying notes are an integral part of these condensed interim consolidated financial statements.